» Articles » PMID: 33690009

Association of Acrylamide Hemoglobin Biomarkers with Serum Lipid Levels in General US Population: NHANES 2013-2016

Overview
Publisher Elsevier
Date 2021 Mar 10
PMID 33690009
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of present study was to investigate the association of acrylamide (AA) hemoglobin biomarkers and serum lipids level in a general population. Data set of our study were extracted from an open database - National Health and Nutrition Examination Surveys (NHANES) 2013-2016. In total 2899 participants were enrolled. The associations between AA hemoglobin parameters [hemoglobin adducts of AA (HbAA) and glycidamide (HbGA), total of HbAA and HbGA (HbAA+HbGA), and ratio of HbGA to HbAA (HbGA/HbAA)] and lipid levels [total cholesterol (TC), triglyceride (TG), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C)] were analyzed. Generalized linear models and restricted cubic spline plots were conducted to address the relationship between lipid levels and acrylamide markers. Comparing the lowest quantiles, HbGA and HbGA/HbAA both remained a significant trend regardless of lipid types. Analyses using a generalized linear model with restricted cubic spline and validated with regression models, all 4 AA parameters demonstrated a linear association and positive correlation with TG. Furthermore, there were also opposite nonlinear association between HbGA/HbAA and LDL-C (positive correlation), and HbGA/HbAA and HDL-C (negative correlation). Further analysis with threshold effect analysis or regression analysis showed HbGA and HbGA/HbAA remained significant association with all TC, TG, LDL-C, and HDL-C. The hemoglobin adducts AA parameters as long-term exposure biomarkers are associated with the atherosclerotic lipid changes in a population of US adults.

Citing Articles

Acrylamide Exposure and Cardiovascular Risk: A Systematic Review.

Merida D, Rey-Garcia J, Moreno-Franco B, Guallar-Castillon P Nutrients. 2025; 16(24.

PMID: 39770901 PMC: 11677207. DOI: 10.3390/nu16244279.


Re-expressing coefficients from regression models for inclusion in a meta-analysis.

Linakis M, Van Landingham C, Gasparini A, Longnecker M BMC Med Res Methodol. 2024; 24(1):6.

PMID: 38191310 PMC: 10773134. DOI: 10.1186/s12874-023-02132-y.


The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study.

Hosseini-Esfahani F, Beheshti N, Nematollahi A, Koochakpoor G, Verij-Kazemi S, Mirmiran P Sci Rep. 2023; 13(1):8235.

PMID: 37217800 PMC: 10203125. DOI: 10.1038/s41598-023-35493-x.


From a toxin to an obesogen: a review of potential obesogenic roles of acrylamide with a mechanistic approach.

Buyukdere Y, Akyol A Nutr Rev. 2023; 82(1):128-142.

PMID: 37155834 PMC: 10711450. DOI: 10.1093/nutrit/nuad041.


The Association Between Exposure to Acrylamide and Mortalities of Cardiovascular Disease and All-Cause Among People With Hyperglycemia.

Wu H, Sun X, Jiang H, Hu C, Xu J, Sun C Front Cardiovasc Med. 2022; 9:930135.

PMID: 35924219 PMC: 9339995. DOI: 10.3389/fcvm.2022.930135.